James et al., 1989 - Google Patents
Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domainJames et al., 1989
View PDF- Document ID
- 5479442143996790818
- Author
- James P
- Vorherr T
- Krebs J
- Morelli A
- Castello G
- McCormick D
- Penniston J
- De Flora A
- Carafoli E
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
The activity of the membrane-bound and the purified erythrocyte Ca 2+-ATPase in the absence of calmodulin was stimulated by calpain digestion but could be further increased to maximal levels by calmodulin (CaM). Thus, CaM sensitivity was retained by the digested …
- 102000000584 Calmodulin 0 title abstract description 153
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Similar Documents
Publication | Publication Date | Title |
---|---|---|
James et al. | Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain | |
AU666854B2 (en) | ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting | |
Jakubowski et al. | The effect of bovine thrombomodulin on the specificity of bovine thrombin. | |
Mimuro et al. | Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix: evidence that the protein is vitronectin | |
Brass et al. | Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. | |
Morita et al. | Preparation and properties of derivatives of bovine factor X and factor Xa from which the gamma-carboxyglutamic acid containing domain has been removed. | |
Gans et al. | α1-antitrypsin, an inhibitor for thrombin and plasmin | |
Kunitake et al. | Pre-beta high density lipoprotein. Unique disposition of apolipoprotein AI increases susceptibility to proteolysis. | |
Keller et al. | Thrombin-catalyzed activation of recombinant human factor V | |
Sim et al. | [5] Preparation and properties of human C1 inhibitor | |
Aulak et al. | Dysfunctional C1-inhibitor (At), isolated from a type II hereditary-angio-oedema plasma, contains a P1'reactive centre'(Arg444----His) mutation | |
Kincaid et al. | Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase. | |
Sziegoleit | A novel proteinase from human pancreas | |
James et al. | Mechanism of inhibition of porcine elastase by human alpha-1-antitrypsin | |
Beullens et al. | Characterization of a ribosomal inhibitory polypeptide of protein phosphatase‐1 from rat liver | |
Estell et al. | Dermasterias imbricata trypsin 1: an enzyme which rapidly hydrolyzes the reactive-site peptide bonds of protein trypsin inhibitors | |
Corbin et al. | Serum carboxypeptidase B: a spectrophotometric assay using protamine as substrate | |
Tsukahara et al. | An ATP‐dependent protease and ingensin, the multicatalytic proteinase, in K562 cells | |
Braun et al. | Preparation and characterization of proteolyzed forms of human α-thrombin | |
Chuah et al. | Calcium-dependent and phosphorylation-stimulated proteolysis of lipocortin I by an endogenous A431 cell membrane protease | |
Andreasen et al. | Solvent effects on activity and conformation of plasminogen activator inhibitor-1 | |
Zeheb et al. | Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1 | |
Goldberg et al. | Protein degradation by the proteasome and dissection of its in vivo importance with synthetic inhibitors | |
Fiedel et al. | Cleaved forms of C-reactive protein are associated with platelet inhibition. | |
Johnson et al. | Localization of felodipine (dihydropyridine) binding site on calmodulin |